Lineage Cell Therapeutics
LCTX
#8509
Rank
ยฃ0.19 B
Marketcap
ยฃ0.77
Share price
-3.74%
Change (1 day)
-9.63%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : ยฃ42.67 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's total liabilities are ยฃ42.67 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lineage Cell Therapeutics - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31ยฃ51.41 M78.2%
2024-12-31ยฃ28.85 M-5.74%
2023-12-31ยฃ30.6 M-28.41%
2022-12-31ยฃ42.75 M-31%
2021-12-31ยฃ61.96 M558.76%
2020-12-31ยฃ9.4 M-13.32%
2019-12-31ยฃ10.85 M46.33%
2018-12-31ยฃ7.41 M11.64%
2017-12-31ยฃ6.64 M-32.06%
2016-12-31ยฃ9.77 M-20.45%
2015-12-31ยฃ12.29 M57.12%
2014-12-31ยฃ7.82 M-16.58%
2013-12-31ยฃ9.37 M177.88%
2012-12-31ยฃ3.37 M19.98%
2011-12-31ยฃ2.81 M12.86%
2010-12-31ยฃ2.49 M69.01%
2009-12-31ยฃ1.47 M-59.85%
2008-12-31ยฃ3.67 M126.47%
2007-12-31ยฃ1.62 M26.26%
2006-12-31ยฃ1.28 M2.76%
2005-12-31ยฃ1.24 M103.9%
2004-12-31ยฃ0.61 M-68.69%
2003-12-31ยฃ1.95 M17.69%
2002-12-31ยฃ1.66 M18.2%
2001-12-31ยฃ1.4 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ORIC Pharmaceuticals
ORIC
ยฃ15.92 M-62.69%๐Ÿ‡บ๐Ÿ‡ธ USA